One million cases of tuberculosis (TB) are estimated in children worldwide; of whom 75% occur in 22 high-burden countries. Tuberculosis is among the 10 main causes of mortality in children with a universal estimation of 130,000 deaths per year (
1). Cavitary pulmonary TB, adult type TB, is rare in children (
2). However, cavities are related to a high mycobacterium load which act as a source of infection in these children and are often nonresponsive to therapy (
2,
3). The proportion of adults with pulmonary TB who have a cavitary disease at the time of diagnosis has been recognized in the studies (
4-
6). However, the data available on cavitary pulmonary TB in children is sparse and inconclusive. Furthermore, TB varies between children and adults in different aspects such as pathophysiological and immunological responses that can affect the diagnosis, prevention, and treatment in children (
7).